Franklin Biotechnology Discovery Fund Investor Sentiment

FRBRX Fund  USD 138.96  2.30  1.68%   
Slightly above 53% of Franklin Biotechnology's investors are presently thinking to get in. The analysis of overall sentiment of trading Franklin Biotechnology Discovery mutual fund suggests that some investors are interested at this time. Franklin Biotechnology's investor sentiment overview provides quick insight into current market opportunities from investing in Franklin Biotechnology Discovery. The current market sentiment, together with Franklin Biotechnology's historical and current headlines, can help investors time the market. In addition, many technical investors use Franklin Biotechnology fund news signals to limit their universe of possible portfolio assets and to time the market correctly.
Franklin Biotechnology mutual fund news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Franklin daily returns and investor perception about the current price of Franklin Biotechnology Discovery as well as its diversification or hedging effects on your existing portfolios.
  
2 days ago at finance.yahoo.com         
The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
Yahoo News
3 days ago at zacks.com         
Biotech Stock Roundup BIIB, BMYs Q1 Earnings, INCYs Acquisition Updates from VRTX
zacks News
few days ago at businesswire.com         
Incyte anuncia adquisicin de Escient Pharmaceuticals y su lnea de antagonistas orales MRGPR de prime...
businesswire News
few days ago at investing.com         
Incyte shares target cut to 84 by Oppenheimer on acquisition outlook
Investing News at Macroaxis
few days ago at businesswire.com         
Samenvatting Incyte kondigt overname aan van Escient Pharmaceuticals en pijplijn van eersteklas oral...
businesswire News
few days ago at businesswire.com         
Samenvatting Incyte kondigt overname aan van Escient Pharmaceuticals en pijplijn van eersteklas oral...
businesswire News
over a week ago at finance.yahoo.com         
Innovent Announces the Appointment of Dr. Nageatte Ibrahim as the Oncology Chief Medical Officer
Yahoo News
over a week ago at finance.yahoo.com         
The past three years for Incyte investors has not been profitable
Yahoo News
over two weeks ago at finance.yahoo.com         
Want Better Returns Dont Ignore These 2 Medical Stocks Set to Beat Earnings
Yahoo News
over two weeks ago at statnews.com         
Pfizers plot to win the RSV vaccine race
news
over a year ago at finance.yahoo.com         
Orphan Drug Market Size Share to Surpass 3199.3 Billion by 2028 Vantage Market Research
Yahoo News
2 days ago at globenewswire.com         
Array Hosts U.S. Energy Secretary Granholm, New Mexico Senators to Break Ground on New Solar Manufac...
Macroaxis News: globenewswire.com
over a week ago at globenewswire.com         
Array Technologies, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call
Macroaxis News: globenewswire.com
over two weeks ago at simplywall.st         
Should You Be Excited About Array Technologies, Inc.s 22 percent Return On Equity?
Simply Wall St News at Macroaxis
over two weeks ago at news.google.com         
Array Technologies, Inc. Stock Sinks As Market Gains What You Should Know - Yahoo News Canada
Google News at Macroaxis
over three weeks ago at investing.com         
Barclays expects Array Technologies to take back share, upgrades stock to Overweight
Investing News at Macroaxis
over a month ago at benzinga.com         
Whats Going On With Array Technologies Stock?
benzinga news
over a month ago at simplywall.st         
Is There An Opportunity With Array Technologies, Inc.s 49 percent Undervaluation?
Simply Wall St News at Macroaxis
over a month ago at investing.com         
BMO sets 16 target on Array Technologies shares
Investing News at Macroaxis
over a month ago at news.google.com         
Disposition of 1311 shares by Neil Manning of Array TechnologiesInc at 11.73 subject to Rule 16b-3
Google News at Macroaxis
over a month ago at investing.com         
Disposition of 405 shares by Travis Rose of Array TechnologiesInc at 14.14 subject to Rule 16b-3
Investing News at Macroaxis
over a year ago at finance.yahoo.com         
Antibody Drug Conjugates Global Market Report 2023
Yahoo News
a day ago at express.co.uk         
Life transformed for five-year-old... all thanks to wonder cystic fibrosis drug
news
2 days ago at newsbtc.com         
Vertex AI Price Forecast Bitcoin Has 60 percent Chance Of Hitting 100,000, Key Predictions Unveiled
Newsbtc at Macroaxis
3 days ago at zacks.com         
Vertex Pharmaceuticals Falls More Steeply Than Broader Market What Investors Need to Know
zacks News
few days ago at marketbeat.com         
Galvin, Gaustad Stein, LLC Top Holdings and 13F Report
Marketbeat News
few days ago at finance.yahoo.com         
Anteriad Rebrands BNZSA, Expands Global Footprint, and Rolls Out New Solutions
Yahoo News
few days ago at finance.yahoo.com         
Global Diabetic Neuropathy Treatment Market Size, Share Trends Analysis Report 2024-2030
Yahoo News
few days ago at investing.com         
Vertex announces 250 million convertible notes offering
Investing News at Macroaxis
over a week ago at zacks.com         
Vertex Pharmaceuticals Gains As Market Dips What You Should Know
zacks News
over a week ago at finance.yahoo.com         
Vertex begins bid for US approval of non-opioid painkiller
Yahoo News
over a week ago at chainlinktoday.com         
Vertex Optimizes User Experience With Chainlink Data Streams
news
over three months ago at reuters.com         
Pfizer forecasts 2024 profit, revenue below Wall Street expectations
reuters
over three months ago at seekingalpha.com         
Pfizer stock slips as 2024 guidance disappoints
seekingalpha News
over three months ago at cnbc.com         
Why investors should only trade a name like Linde on fundamentals
cnbc News
over three months ago at finance.yahoo.com         
Were Interested To See How Seagen Uses Its Cash Hoard To Grow
Yahoo News
over three months ago at businesswire.com         
ADCETRIS Plus Novel Immunotherapy Combination Delivers 100 percent Progression Free Survival at 12 m...
businesswire News
over three months ago at businesswire.com         
ADCETRIS Plus Novel Immunotherapy Combination Delivers 100 percent Progression Free Survival at 12 m...
businesswire News
over three months ago at dragonflycap.com         
5 Trade Ideas for MondayArista, Comerica, Interactive Brokers, Seagen and Teck Resources
news
over three months ago at benzinga.com         
100 Invested In Seagen 20 Years Ago Would Be Worth This Much Today
benzinga news
over three months ago at businesswire.com         
TUKYSA in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Fr...
businesswire News
over three months ago at thelincolnianonline.com         
Seagen Inc. Receives 193.00 Average PT from Analysts
news
over six months ago at www.macroaxis.com         
Disposition of 49701 shares by Michael Wortley of Reata Pharmaceuticals subject to Rule 16b-3
Macroaxis News
over six months ago at news.google.com         
Reata Pharmaceuticals, Inc. Is Expected To Breakeven In The Near Future - Yahoo Finance
Google News at Macroaxis
over six months ago at thelincolnianonline.com         
Reata Pharmaceuticals Research Coverage Started at StockNews.com
news
over six months ago at thelincolnianonline.com         
Reata Pharmaceuticals, Inc. Stock Holdings Trimmed by Swiss National Bank
news
over six months ago at thelincolnianonline.com         
StockNews.com Begins Coverage on Reata Pharmaceuticals
news
over six months ago at www.macroaxis.com         
Sale by Michael Wortley of 807 shares of Reata Pharmaceuticals
Macroaxis News
over six months ago at zacks.com         
Alimera Sciences Reports Q2 Loss, Lags Revenue Estimates
zacks News
over six months ago at zacks.com         
Entrada Therapeutics, Inc. Reports Q2 Loss, Misses Revenue Estimates
zacks News
over six months ago at Macroaxis         
Should you quit your Reata Pharmaceuticals (USA Stocks:RETA) holdings?
Macroaxis News
over six months ago at thelincolnianonline.com         
Reata Pharmaceuticals Cut to Neutral at LADENBURG THALMSH SH
news
18 hours ago at finance.yahoo.com         
11 Oversold Growth Stocks to Buy Right Now
Yahoo News
3 days ago at finance.yahoo.com         
Sanofi Q1 2024 Earnings Call Transcript
Yahoo News
few days ago at investing.com         
TD Cowen lifts Regeneron stock PT to 1,030 despite recent pullback
Investing News at Macroaxis
few days ago at globenewswire.com         
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad R...
Macroaxis News: globenewswire.com
few days ago at finance.yahoo.com         
Agenus Soars 6.8 percent Is Further Upside Left in the Stock?
Yahoo News
few days ago at globenewswire.com         
Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Th...
Macroaxis News: globenewswire.com
over a week ago at finance.yahoo.com         
Roche Alecensa Wins FDA Nod for Label Expansion
Yahoo News
over a week ago at benzinga.com         
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Regeneron Pharmaceuticals,...
benzinga news
over a week ago at businesswire.com         
The Law Offices of Frank R. Cruz Announces Investigation of Regeneron Pharmaceuticals, Inc. on Behal...
businesswire News
over a week ago at finance.yahoo.com         
COVID-19 Drug Pipeline Landscape Report 2024 Comprehensive Insights on 400 Companies and 400 Pipelin...
Yahoo News
18 hours ago at finance.yahoo.com         
Industry Analysts Just Made A Captivating Upgrade To Their PTC Therapeutics, Inc. Revenue Forecasts
Yahoo News
2 days ago at finance.yahoo.com         
Compared to Estimates, PTC Therapeutics Q1 Earnings A Look at Key Metrics
Yahoo News
3 days ago at gurufocus.com         
PTC Therapeutics Q1 2024 Earnings A Detailed Financial Review
Gurufocus Stories at Macroaxis
3 days ago at investing.com         
PTC Therapeutics earnings beat by 0.09, revenue topped estimates
Investing News at Macroaxis
few days ago at investing.com         
PTC Therapeutics CEO sells shares worth over 83,000
Investing News at Macroaxis
over a week ago at investing.com         
Disposition of 3361 shares by Klein Matthew B. of PTC Therapeutics at 24.894 subject to Rule 16b-3
Investing News at Macroaxis
over a week ago at www.macroaxis.com         
Disposition of 1307 shares by Klein Matthew B. of PTC Therapeutics at 25.135 subject to Rule 16b-3
Macroaxis News
over two weeks ago at finance.yahoo.com         
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results
Yahoo News
over three weeks ago at investing.com         
PTC Therapeutics executive sells over 14k in company stock
Investing News at Macroaxis
over three weeks ago at news.google.com         
Vanguard Group Inc. Raises Holdings in PTC Therapeutics, Inc. - MarketBeat
Google News at Macroaxis
3 days ago at zerohedge.com         
COVID-19 Vaccine Protection Among Children Plummets Within Months CDC Study
news
six days ago at fool.com         
These Biotech Stocks Could Soar 120 percent and 295, According to Wall Street
fool News
over a week ago at accesswire.com         
Levi Korsinsky, LLP Notifies Shareholders of Novavax, Inc. an Upcoming Claims Deadline in a Class Ac...
news
over a week ago at phys.org         
How can companies address consumers who are averse to products using a novel technology?
news
over a week ago at investing.com         
Shah Capital proposes new directors for Novavax board
Investing News at Macroaxis
over a week ago at benzinga.com         
Whats Going On With Novavax Stock Today?
benzinga news
over two weeks ago at fool.com         
Down 60 percent From Its 52-Week High, Is Novavax Stock a Buy?
fool News
over two weeks ago at oregonlive.com         
Oregon study finds no link between COVID-19 vaccine, cardiac deaths in younger people
news
over two weeks ago at finance.yahoo.com         
On eve of Japanese prime ministers visit to North Carolina, Fujifilm announces more jobs there
Yahoo News
over two weeks ago at ajc.com         
On eve of Japanese prime ministers visit to North Carolina, Fujifilm announces more jobs there
news
over three months ago at thelincolnianonline.com         
Mirati Therapeutics Now Covered by Analysts at StockNews.com
news
over three months ago at finance.yahoo.com         
Billionaire Joe Lewis Pleads Guilty in Insider Trading Case
Yahoo News
over three months ago at smh.com.au         
Billionaire pleads guilty in insider trading case with a link to an Australian giant
news
over three months ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over three months ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over three months ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over three months ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over three months ago at aol.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
news
over three months ago at seekingalpha.com         
Mirati Therapeutics stock ticks higher amid Nasdaq delisting for sale to Bristol-Myers
seekingalpha News
over three months ago at thelincolnianonline.com         
Brokerages Set Mirati Therapeutics, Inc. PT at 60.00
news
3 days ago at 48hills.org         
Screen Grabs Stylish but deadly classic Le Samourai swings into the Roxie
news
few days ago at zacks.com         
Jazz Pharmaceuticals Earnings Expected to Grow What to Know Ahead of Next Weeks Release
zacks News
few days ago at 48hills.org         
After painful preparation, Blue Door opens onto Black mens complex life in US
news
few days ago at finance.yahoo.com         
A Closer Look At Jazz Pharmaceuticals plcs Uninspiring ROE
Yahoo News
over a week ago at seekingalpha.com         
Eli Lilly stock gains as Zepbound succeeds in sleep apnea
seekingalpha News
over a week ago at finance.yahoo.com         
Acquisition by Seamus Mulligan of 4500 shares of Jazz Pharmaceuticals at 81.76 subject to Rule 16b-3
Yahoo News
over a week ago at benzinga.com         
London Research Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate...
benzinga news
over two weeks ago at aol.com         
CJ McCollum scores 28 points as Pelicans hold off Warriors 114-109 to boost playoff position
news
over two weeks ago at finance.yahoo.com         
Jazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at American Academy of Neurology A...
Yahoo News
over two weeks ago at cnbc.com         
How this UK-based firm is growing a more sustainable cannabis
cnbc News
3 days ago at zacks.com         
Will Intra-Cellular Therapies Report Negative Q1 Earnings What You Should Know
zacks News
few days ago at finance.yahoo.com         
Disposition of 8638 shares by Sharon Mates of Intracellular at 16.86 subject to Rule 16b-3
Yahoo News
few days ago at investing.com         
Mizuho raises Intra-Cellular stock target to on Caplyta data
Investing News at Macroaxis
over a week ago at seekingalpha.com         
Intra-Cellular Therapies drops 2, prices 500M equity financing
seekingalpha News
over a week ago at finance.yahoo.com         
Intra-Cellular Moves 23.3 percent Higher Will This Strength Last?
Yahoo News
over a week ago at globenewswire.com         
Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumate...
Macroaxis News: globenewswire.com
over a week ago at investing.com         
Lumateperone shows promise in major depression study
Investing News at Macroaxis
over a week ago at medcitynews.com         
Depression Trial Win Moves Intra-Cellular Drug Closer to Label Expansion Blockbuster Status
news
over two weeks ago at simplywall.st         
Intra-Cellular Therapies, Inc.s PS Is On The Mark
Simply Wall St News at Macroaxis
over a month ago at finance.yahoo.com         
Intra-Cellular Therapies advances 6.5 percent this week, taking five-year gains to 467
Yahoo News
a day ago at news.google.com         
When Will Iovance Biotherapeutics, Inc. Become Profitable - Simply Wall St
Google News at Macroaxis
3 days ago at fool.com         
3 Millionaire-Maker Biotech Stocks
fool News
six days ago at finance.yahoo.com         
These Biotech Stocks Could Soar 120 percent and 295, According to Wall Street
Yahoo News
over a week ago at finance.yahoo.com         
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635
Yahoo News
over two weeks ago at finance.yahoo.com         
Market Sentiment Around Loss-Making Iovance Biotherapeutics, Inc.
Yahoo News
over three weeks ago at news.google.com         
SG Americas Securities LLC Has 721,000 Stock Position in Iovance Biotherapeutics, Inc. - MarketBeat
Google News at Macroaxis
over three weeks ago at simplywall.st         
Iovance Biotherapeutics pulls back 3.5 percent this week, but still delivers shareholders solid 141 ...
Simply Wall St News at Macroaxis
over a month ago at finance.yahoo.com         
2 Soaring Growth Stocks That Could Climb Another 47 percent to 73, According to Wall Street
Yahoo News
over a month ago at globenewswire.com         
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635
Macroaxis News: globenewswire.com
over a month ago at finance.yahoo.com         
Iovance Biotherapeutics shareholders are still up 122 percent over 1 year despite pulling back 7.1 p...
Yahoo News
over six months ago at news.google.com         
Form 485BPOS INSTITUTIONAL FIDUCIARY - StreetInsider.com
Google News at Macroaxis
2 days ago at simplywall.st         
Calculating The Fair Value Of Illumina, Inc.
Simply Wall St News at Macroaxis
3 days ago at phys.org         
Sweetpotato genetics A comprehensive update to the Taizhong 6 genome annotation
news
few days ago at medcitynews.com         
FTC Chief Says Tech Advancements Risk Healthcare Price Fixing
news
few days ago at finance.yahoo.com         
Illumina investors are sitting on a loss of 71 percent if they invested three years ago
Yahoo News
few days ago at finance.yahoo.com         
Xaira Therapeutics Launches to Deliver Transformative Medicines by Advancing and Harnessing AI for D...
Yahoo News
few days ago at businesswire.com         
Moonwalk Biosciences to Present Data Showcasing EpiRead and EpiWrite Next-Generation Multiplex Epige...
businesswire News
over a week ago at finance.yahoo.com         
Global RNA Analysis Market Forecast, 2028 Rising RNA-Seq Data Volume Spurs Demand for Advanced Bioin...
Yahoo News
over a week ago at finance.yahoo.com         
20 Countries with the Highest Cancer Survival Rates in the World
Yahoo News
over a week ago at businesswire.com         
Delve Bio presents study showing utility of metagenomic next generation sequencing in diagnosing neu...
businesswire News
over a week ago at businesswire.com         
Delve Bio presents study showing utility of metagenomic next generation sequencing in diagnosing neu...
businesswire News
over six months ago at www.macroaxis.com         
Disposition of 110447 shares by Thomas Watkins of Horizon Pharma subject to Rule 16b-3
Macroaxis News
over six months ago at news.google.com         
Institutional owners may consider drastic measures as Vir Biotechnology, Inc.s recent US85m drop add...
Google News at Macroaxis
over six months ago at businesswire.com         
Horizon Therapeutics plc Rule 2.12 Announcement
businesswire News
over six months ago at benzinga.com         
Heres How Much 1000 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth Today
benzinga news
over six months ago at news.google.com         
U.S. FTC allows Amgen to move forward with 27.8 bln Horizon deal - CNBC - Marketscreener.com
Google News at Macroaxis
over six months ago at thelincolnianonline.com         
Toronto Dominion Bank Buys 185,145 Shares of Horizon Therapeutics Public Limited
news
over six months ago at finance.yahoo.com         
Horizon Up as FTC Pauses Acquisition by Amgen Lawsuit
Yahoo News
over six months ago at finance.yahoo.com         
Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocac...
Yahoo News
over six months ago at marketwatch.com         
George Soros has a big stake in this stock but its posted a roughly 9 percent loss this year. Are th...
marketwatch News
over six months ago at thelincolnianonline.com         
Horizon Therapeutics Public Issues Earnings Results
news
18 hours ago at finance.yahoo.com         
Business People Sean Dols moves up the ranks at Knutson Construction
Yahoo News
2 days ago at seekingalpha.com         
Gilead Sciences declares 0.77 dividend
seekingalpha News
3 days ago at zacks.com         
Gilead Reports Q1 Earnings What Key Metrics Have to Say
zacks News
3 days ago at investorplace.com         
Disposition of 158 shares by Deborah Telman of Gilead Sciences at 65.27 subject to Rule 16b-3
sbwire news
few days ago at marketbeat.com         
Milestone Asset Management, LLC Top Holdings and 13F Report
Marketbeat News
few days ago at zacks.com         
Incyte Earnings Expected to Grow Should You Buy?
zacks News
few days ago at simplywall.st         
Gilead Sciences, Inc.s PE Is On The Mark
Simply Wall St News at Macroaxis
over a week ago at nypost.com         
Inside the world of a silent nun
news
over a week ago at zacks.com         
Gilead Sciences Increases Despite Market Slip Heres What You Need to Know
zacks News
over a week ago at zacks.com         
Analysts Estimate Gilead Sciences to Report a Decline in Earnings What to Look Out for
zacks News
a day ago at news.google.com         
Allspring Global Investments Holdings LLC Cuts Holdings in Deciphera Pharmaceuticals, Inc. - MarketB...
Google News at Macroaxis
over a week ago at news.google.com         
Deciphera Pharmaceuticals, Inc. Sees Significant Increase in Short Interest - MarketBeat
Google News at Macroaxis
over two weeks ago at finance.yahoo.com         
Deciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forum
Yahoo News
over a month ago at www.macroaxis.com         
Disposition of 2403 shares by Daniel Flynn of Deciphera Pharmaceuticals at 21.2413 subject to Rule 1...
Macroaxis News
over a month ago at news.google.com         
Deciphera Pharmaceuticals Given New 16.00 Price Target at JPMorgan Chase Co. - MarketBeat
Google News at Macroaxis
over a month ago at zacks.com         
Why Is Biogen Inc. Up 2.6 percent Since Last Earnings Report?
zacks News
over a month ago at news.google.com         
Hsbc Holdings PLC Has 237000 Position in Deciphera Pharmaceuticals, Inc. - Defense World
Google News at Macroaxis
over a month ago at zacks.com         
Why Is Deciphera Pharmaceuticals, Inc. Up 20.8 percent Since Last Earnings Report?
zacks News
over a month ago at thelincolnianonline.com         
Q1 2024 EPS Estimates for Deciphera Pharmaceuticals, Inc. Decreased by Zacks Research
news
over a month ago at thelincolnianonline.com         
Analysts Issue Forecasts for Deciphera Pharmaceuticals, Inc.s FY2026 Earnings
news
a minute ago at kalkinemedia.com         
Japan gives priority review status to Alzheimers drug developed by Eisai, Biogen
news
2 days ago at finance.yahoo.com         
C2N Diagnostics Expands Into Japan Through Mediford Corporation Partnership With Precivity Blood Tes...
Yahoo News
3 days ago at insidermonkey.com         
Biogen Inc. Q1 2024 Earnings Call Transcript
insidermonkey News
3 days ago at finance.yahoo.com         
McKinney Named Ad Age A-List Agency Standout at Awards Gala
Yahoo News
few days ago at investing.com         
Earnings call Biogen reports growth and optimistic outlook for 2024
Investing News at Macroaxis
few days ago at foxnews.com         
Alzheimers drug embrace slows down as US doctors reluctance grows
foxnews news
over a week ago at finance.yahoo.com         
BioArctic and Eisai sign research evaluation agreement regarding BAN2802
Yahoo News
over a week ago at forbes.com         
Pfizer On The New Lows List. Big Dividend Fails To Attract Buyers.
Usa forbes News
over a week ago at finance.yahoo.com         
Alzheimers Therapeutics Market Size Expected to Surpass USD 8.18 Bn by 2032
Yahoo News
over a week ago at finance.yahoo.com         
Blood Screening Market to Grow at CAGR of 11.6 percent through 2033 High Investment in Blood Transfu...
Yahoo News
3 days ago at globenewswire.com         
Ascendis Pharma to Report First Quarter 2024 Financial Results and Provide Business Update on May 2,...
Macroaxis News: globenewswire.com
few days ago at zacks.com         
Why Earnings Season Could Be Great for Ascendis Pharma
zacks News
over a week ago at benzinga.com         
1000 Invested In Ascendis Pharma 15 Years Ago Would Be Worth This Much Today
benzinga news
over a week ago at news.google.com         
Ascendis Pharma AS Stock Position Reduced by Allspring Global Investments Holdings LLC - MarketBeat
Google News at Macroaxis
over three weeks ago at simplywall.st         
Some Confidence Is Lacking In Ascendis Pharma AS PS
Simply Wall St News at Macroaxis
over three weeks ago at news.google.com         
Ascendis Pharma AS Earns Overweight Rating from Cantor Fitzgerald - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
ASCENDIS PHARMA AS Revenue Breakdown TRADEGATEA71 TradingView - TradingView
Google News at Macroaxis
over a month ago at investors.com         
Two Health Care Stocks Outperform SP 500, Offer Entries
Investors Business Daily at Macroaxis
over a month ago at news.google.com         
Wells Fargo Company Increases Ascendis Pharma AS Price Target to 260.00 - Defense World
Google News at Macroaxis
over a month ago at investing.com         
Evercore ISI raises Ascendis Pharma stock target to 191
Investing News at Macroaxis
3 days ago at zacks.com         
Intellia to Report Q1 Earnings Whats in the Cards?
zacks News
over three weeks ago at gurufocus.com         
Harbor Capital Appreciation Fund Adjusts Portfolio, NVIDIA Corp Sees a 2.1 percent Impact
Gurufocus Stories at Macroaxis
over a month ago at benzinga.com         
argenx Announces Approval of VYVGART in Japan for Adults with Primary Immune Thrombocytopenia
benzinga news
over a month ago at zacks.com         
Why Argenxs Stock Price Moved Up 11 percent on Thursday
zacks News
over a month ago at finance.yahoo.com         
Reasons to Invest in argenx
Yahoo News
over a month ago at thelincolnianonline.com         
argenx PT Raised to 440.00
news
over a month ago at thelincolnianonline.com         
Sectoral Asset Management Inc. Boosts Stock Position in argenx SE
news
over a month ago at investing.com         
Truist raises Argenx target to 440 on CIDP, Sjogrens treatment prospects
Investing News at Macroaxis
over a month ago at insidermonkey.com         
argenx SE Q4 2023 Earnings Call Transcript
insidermonkey News
over a month ago at zacks.com         
Is a Surprise Coming for argenx This Earnings Season?
zacks News
just now at marketbeat.com         
Tnf LLC Top Holdings and 13F Report
Marketbeat News
2 days ago at finance.yahoo.com         
AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY
Yahoo News
3 days ago at benzinga.com         
Drugmaker Sanofis Strong Dupixent And Beyfortus Vaccine Sales Propel Q1 Earnings
benzinga news
3 days ago at finance.yahoo.com         
Disposition of 2508 shares by Matthew Busch of Amgen at 235.97 subject to Rule 16b-3
Yahoo News
few days ago at marketbeat.com         
Verum Partners LLC Top Holdings and 13F Report
Marketbeat News
few days ago at finance.yahoo.com         
Better Buy Pfizer vs. Viking Therapeutics
Yahoo News
few days ago at cnbc.com         
A pullback in this biotech stock has created a buying opportunity, according to the charts
cnbc News
few days ago at prnewswire.com         
Autoinjectors Market size is set to grow by USD 134.01 billion from 2023-2027, AbbVie Inc., Amgen In...
prnewswire News
over a week ago at www.macroaxis.com         
Disposition of 2508 shares by Matthew Busch of Amgen at 235.97 subject to Rule 16b-3
Macroaxis News
over a week ago at investing.com         
Disposition of 2508 shares by Matthew Busch of Amgen at 235.97 subject to Rule 16b-3
Investing News at Macroaxis
few days ago at news.google.com         
BioMarin shares fall on slight revenue miss, despite EPS beat - Investing.com
Google News at Macroaxis
over a week ago at news.google.com         
Leerink Partnrs Analysts Lower Earnings Estimates for BioMarin Pharmaceutical Inc. - MarketBeat
Google News at Macroaxis
over a week ago at investing.com         
Biomarin CEO sells over 3.6m in company stock
Investing News at Macroaxis
over two weeks ago at investing.com         
BioMarin executive sells over 200k in company stock
Investing News at Macroaxis
over two weeks ago at finance.yahoo.com         
Disposition of 20000 shares by Bienaime Jean Jacques of Biomarin Pharmaceutical at 63.1 subject to R...
Yahoo News
over two weeks ago at www.macroaxis.com         
Disposition of 1000 shares by Bienaime Jean Jacques of Biomarin Pharmaceutical at 90.35 subject to R...
Macroaxis News
over three weeks ago at news.google.com         
Looking Into Biomarin Pharmaceuticals Recent Short Interest - Biomarin Pharmaceutical - Benzinga
Google News at Macroaxis
over three weeks ago at simplywall.st         
Is BioMarin Pharmaceutical Using Too Much Debt?
Simply Wall St News at Macroaxis
over a month ago at finance.yahoo.com         
Global Skeletal Dysplasia Market Projected to Reach USD 3.92 Billion by 2028, Growing at a CAGR of 7...
Yahoo News
over a month ago at news.google.com         
Gulf International Bank UK Ltd Trims Stock Position in BioMarin Pharmaceutical Inc. - Defense World
Google News at Macroaxis
a day ago at simplywall.st         
Neurocrine Biosciences, Inc.s Price In Tune With Earnings
Simply Wall St News at Macroaxis
3 days ago at finance.yahoo.com         
Zoetis Earnings Expected to Grow What to Know Ahead of Next Weeks Release
Yahoo News
few days ago at cnbc.com         
Wells Fargo becomes bullish on this biotech company
cnbc News
few days ago at finance.yahoo.com         
Neurocrine scores surprise win with depression drug
Yahoo News
over a week ago at news.google.com         
Neurocrine Biosciences, Inc. to Post FY2025 Earnings of 6.58 Per Share, William Blair Forecasts - De...
Google News at Macroaxis
over a week ago at investing.com         
Neurocrine Biosciences exec sells over 2.6m in stock
Investing News at Macroaxis
over a week ago at investing.com         
Sentia and Neurocrine extend collaboration on peptide therapeutics
Investing News at Macroaxis
over two weeks ago at news.google.com         
Neurocrine Biosciences Overweight Rating Reaffirmed at Cantor Fitzgerald - Defense World
Google News at Macroaxis
over three weeks ago at investors.com         
Nvidia, Netflix And This Hot IPO Join List Of 17 Perfect Stocks
Investors Business Daily at Macroaxis
over three weeks ago at investors.com         
Nvidia Isnt The Only Game In Town. Uber Leads 6 Stocks To Watch.
Investors Business Daily at Macroaxis
over a year ago at news.google.com         
Netupitant Palonosetron FDC Market Size is Expected to Exhibit US 532228.43 million by 2028 Eisai Ph...
Google News at Macroaxis
over a year ago at news.google.com         
Content is king Digital materials linked to 2.5 times boost to new ... - FiercePharma
Google News at Macroaxis
3 days ago at finance.yahoo.com         
Heron Therapeutics, Inc.s Profit Outlook
Yahoo News
few days ago at businesswire.com         
Disposition of 4564 shares by Kimberly Manhard of Heron Therapeuti subject to Rule 16b-3
businesswire News
over a week ago at www.macroaxis.com         
Disposition of 42631 shares by Lisa Peraza of Heron Therapeuti subject to Rule 16b-3
Macroaxis News
over two weeks ago at statnews.com         
STAT Up and down the ladder The latest comings and goings
news
over three weeks ago at www.macroaxis.com         
Disposition of 62500 shares by Craig Collard of Heron Therapeuti subject to Rule 16b-3
Macroaxis News
over three weeks ago at news.google.com         
The past three years for Heron Therapeutics investors has not been profitable - Yahoo Movies UK
Google News at Macroaxis
over a month ago at news.google.com         
Does Heron Therapeutics Inc Have What it Takes to be in Your Portfolio Monday - InvestorsObserver
Google News at Macroaxis
over a month ago at cleveland.com         
Predicting the Guardians opening day roster with one week left in training camp
news
over a month ago at simplywall.st         
Heres What Analysts Are Forecasting For Heron Therapeutics, Inc. After Its Full-Year Results
Simply Wall St News at Macroaxis
over a month ago at investing.com         
Needham raises Heron Therapeutics stock PT to 5 on strong 2023 finish
Investing News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Franklin Biotechnology that are available to investors today. That information is available publicly through Franklin media outlets and privately through word of mouth or via Franklin internal channels. However, regardless of the origin, that massive amount of Franklin data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Franklin Biotechnology news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Franklin Biotechnology relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Franklin Biotechnology's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Franklin Biotechnology alpha.
Check out Franklin Biotechnology Hype Analysis, Franklin Biotechnology Correlation and Franklin Biotechnology Performance.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Please note, there is a significant difference between Franklin Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Franklin Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Franklin Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.